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Today, systems biology is rapidly developing in the various areas of biomedical research, including human oncology. So far, functional genomic strategies have largely centred on gene-expression studies (genomics and transcriptomics) or protein level (proteomics). In addition, the biochemistry of a tumour, especially glucose uptake and metabolism, is very different from that of a normal cell: mitochondrial metabolism is impaired and cytosolic glycolysis is elevated with a subsequent increase in glucose uptake (Warburg's effect). In the past years, various specific metabolites have been reported to be associated with cancer development and progression, including citrate, myo-inositol, poly-unsaturated fatty acids (PUFA), nucleotides, phospocholine and other cell membrane
constituents [1] . This makes nuclear magnetic resonance (NMR) ( 1 H, 31 P and 13 C NMR spectroscopy) one of the most valuable techniques to evaluate cancer metabolism and efficacy of the treatment since multiple metabolic pathways can be assessed simultaneously [2] [3] [4] [5] [6] [7] [8] . Despite Fig. 2A and B) Fig. 4A and B) and two-dimensional (COSY, Fig. 4C) 
. Understanding tumour-related processes through metabolic profiling has been widely used in the last decades to differentiate between different cancer cell lines and to monitor metabolic processes that occur in cancer cells during events such as apoptosis, down-stream-pathway regulation and enzyme abnormalities
